about
Alemtuzumab: a review of its use in patients with relapsing multiple sclerosis.Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates.Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The outlook for alemtuzumab in multiple sclerosis.
@en
The outlook for alemtuzumab in multiple sclerosis.
@nl
type
label
The outlook for alemtuzumab in multiple sclerosis.
@en
The outlook for alemtuzumab in multiple sclerosis.
@nl
prefLabel
The outlook for alemtuzumab in multiple sclerosis.
@en
The outlook for alemtuzumab in multiple sclerosis.
@nl
P2093
P2860
P1433
P1476
The outlook for alemtuzumab in multiple sclerosis.
@en
P2093
Alasdair Coles
Laura Azzopardi
Thomas Williams
P2860
P2888
P304
P356
10.1007/S40259-013-0028-3
P577
2013-06-01T00:00:00Z
P6179
1041551572